Mental health conditions continue to defy available treatment options, but Aditum Bio is hoping to rise to the challenge with a new biotech that will take another look at Taisho Pharmaceutical's ...
Venture capital firm Aditum Bio is going all-out for a new collaboration with Fosun Pharma, launching a subsidiary with the sole purpose of developing novel therapies in tandem with the Shanghai-based ...
OAKLAND, Calif., June 30, 2021 /PRNewswire/ -- Aditum Bio, the biotech investment firm co-founded in 2019 by former Novartis CEO Joe Jimenez and former President of the Novartis Institutes for ...
China’s Mabwell Bioscience and US-based Aditum Bio have launched Kalexo Bio, a new company, to develop a new small interfering RNA (siRNA) candidate, 2MW7141. The initiative follows an exclusive ...
SHANGHAI and OAKLAND, Calif., Sept. 17, 2025 /PRNewswire/ -- Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SH) and Aditum Bio today announced the launch of Kalexo Bio, a new company formed in ...
Celexor Bio expected to focus on ell depletion of pathologic cells in autoimmune and inflammatory disorders. Immagene Biopharmaceuticals and Aditum Bio have announced a joint venture to create Celexor ...
Joe Jimenez, best known in biopharma as the ex-CEO of Novartis, has spent the last year-plus starting up something entirely different: a biotech investment firm focused on drug candidates that have ...
NORWALK, Conn.--(BUSINESS WIRE)--Aditum, known for its broadband infrastructure delivery platform giving building owners control over their telecom network in multi-tenant properties announces a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback